Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Feb 04 2026

Feb 4, 2026 at 2:38 PM EST · Issued by Zydus Lifesciences Limited

Filed with NSE · Feb 4, 2026 at 2:38 PM EST · 2 pages · English

On 6ix: 6ix.com/news/press-release-feb-04-2026-4

Release

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 04, 2026, titled "Zydus receives tentative approval from USFDA for Dapagliflozin Tablets, 5 mg and 10 mg".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Press Release Jan 23 2026Jan 23
Press Release Jan 22 2026Jan 22
Press Release Jan 15 2026Jan 15
Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.Jan 15
Press Release Jan 13 2026Jan 13

Later from Zydus Lifesciences

Press Release Feb 06 2026Feb 6
Press Release Feb 09 2026Feb 9
Press Release 10-02-2026 NewspaperPublication10022026Feb 10
Zydus Lifesciences Limited Press Release Feb 14 2026Feb 13
Zydus Lifesciences Limited Press Release Feb 17 2026Feb 16

All Zydus Lifesciences news releases

Follow Zydus Lifesciences into a list and get an email when it puts out news.

Follow Zydus Lifesciences